Quick Overview: Panelist field questions from the audience. Panelists field questions from the audience. SUSAN WARD Founder and Executive Director The TAP Collaboration.

10 20 2015 Session Ii - Detailed Overview & Context

Panelist field questions from the audience. Panelists field questions from the audience. SUSAN WARD Founder and Executive Director The TAP Collaboration. RICHARD PLATT Professor and Chair of the Department of Population Medicine Harvard Pilgrim Health Care Institute. CHARLES JAFFE Chief Executive Officer Health level Seven International. ERIC HORVITZ Distinguished Scientist & Managing Director Microsoft Research.

ENRIQUE AVILES Director of Data Standards, Management, and Technology The Critical Path Institute. SHASHI AMUR Scientific Coordinator for CDER's Biomarker Qualification Program U.S. Food and Drug Administration. MARC SALIT Group Leader National Institute of Standards and Technology (NIST) ARIANA ANDERSON Assistant Research Statistician University of California Los Angeles. GABRIELA LAVEZZARI Assistant Vice President, Scientific Affairs Pharmaceutical Research and Manufacturers of America ... PERRY NISEN Chief Executive Officer Sanford Burnham.

BRIAN ALEXANDER Assistant Professor of Radiation Oncology Harvard Medical School. JOHN H. HOLMES Professor of Medical Informatics University of Pennsylvania. MARTIN LANDRAY Professor of Medicine and Epidemiology, Deputy Director Big Data Institute University of Oxford. SANDY ALLERHEILIGEN Vice President Modeling and Simulation Merck. JOHN BROWNSTEIN Associate Professor Harvard Medical School.

Photo Gallery

10/20/2015 - Session II: Panel Discussion
10/20/2015 - Session II: Panel Discussion
10/20/2015 - Session II: Panel Discussion
10/20/2015 - Session II: Panel Discussion
10/20/2015 - Session II: Designing Better Clinical Trials for Duchenne Muscular Dystrophy
10/20/2015 - Session II:  Integrating Systems and Capabilities to Enhance Safety Surveillance
10/20/2015 - Session II:  The BRIDG Initiative
10/20/2015 - Session II: Data-Mining the Internet to Find Unreported Prescription Drug Side Effects
10/20/2015 - Session II: Data Aggregation Across Diseases and Between Stakeholders
10/20/2015 - Session II:  Opportunities to Develop Meaningful Biomarkers
10/20/2015 - Session II: Clinical Trial Design to Measure Cognitive Changes of Alzheimer’s Disease
10/20/2015 - Session II: Basic Science of Measurement
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored